Anna Cheng
MD Student
Boston University Chobanian & Avedisian School of Medicine



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Davoust M, Bazzi AR, Blakemore S, Blodgett J, Cheng A, Fielman S, Magane KM, Theisen J, Saitz R, Ventura AS, Weinstein ZM. Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study. Addict Sci Clin Pract. 2025 Mar 04; 20(1):21.View Related Profiles. PMID: 40033433; PMCID: PMC11877703; DOI: 10.1186/s13722-025-00536-3;
     
  2. Wong G, Cheng A, Cheng K, Masoe A, D'Hary S, Montebello ME. Exploring oral health challenges and integration strategies in opioid treatment programs: perspectives from clinicians and clients. Aust J Prim Health. 2025 Jan; 31. PMID: 39773814
     
  3. Weinstein ZM, Magane KM, Lodi S, Ventura AS, Bazzi AR, Blodgett J, Fielman S, Davoust M, Shea MG, Chen CA, Cheng A, Theisen J, Blakemore S, Saitz R. The Impact of COVID-19 on Substance Use and Related Consequences Among Patients in Office-based Opioid Use Disorder Treatment. J Addict Med. 2025 Jan-Feb 01; 19(1):12-19.View Related Profiles. PMID: 39101572; PMCID: PMC11790372; DOI: 10.1097/ADM.0000000000001367;
     
  4. Wong G, Venkatesha V, Montebello ME, Masoe A, Cheng K, Cook H, Puszka B, Cheng A. Oral health status and oral health-related quality of life: a cross-sectional study of clients in an Australian opioid treatment program. Aust J Prim Health. 2024 Aug; 30. PMID: 39213387
     
  5. Davoust M, Bazzi AR, Blakemore S, Blodgett J, Cheng A, Fielman S, Magane KM, Theisen J, Saitz R, Ventura AS, Weinstein ZM. Patient and Clinician Experiences with the Implementation of Telemedicine and Related Adaptations in Office-Based Buprenorphine Treatment During the COVID-19 Pandemic: A Qualitative Study. Res Sq. 2024 Apr 22.View Related Profiles. PMID: 38746460; PMCID: PMC11092823; DOI: 10.21203/rs.3.rs-4272282/v1;
     
  6. Sugarman A, Vittitow A, Cheng A, Malone M, McDonald R, Pace N, Williams O, Tofighi B, McNeely J, Schatz D, Roberts T, Hey SP, Garrity K, Lindquist K, Lee JD. Opioid Use Disorder Treatments: An Evidence Map. Drug Alcohol Depend. 2022 Dec 01; 241:109657. PMID: 36332588
     
  7. Cheng A, Badolato R, Segoshi A, McDonald R, Malone M, Vasudevan K, Badiei B, Sugarman A, Macdonald R, Mangat J, Giftos J, Lee JD, Tofighi B. Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study. Addict Sci Clin Pract. 2022 Jan 29; 17(1):4. PMID: 35093164; PMCID: PMC8800291; DOI: 10.1186/s13722-022-00288-4;
     
  8. Lin NU, Pegram M, Sahebjam S, Ibrahim N, Fung A, Cheng A, Nicholas A, Kirschbrown W, Kumthekar P. Reply to J. Wei et al. J Clin Oncol. 2021 Dec 20; 39(36):4127-4128. PMID: 34637335
     
  9. Waddell EN, Springer SA, Marsch LA, Farabee D, Schwartz RP, Nyaku A, Reeves R, Goldfeld K, McDonald RD, Malone M, Cheng A, Saunders EC, Monico L, Gryczynski J, Bell K, Harding K, Violette S, Groblewski T, Martin W, Talon K, Beckwith N, Suchocki A, Torralva R, Wisdom JP, Lee JD. Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS). J Subst Abuse Treat. 2021 Sep; 128:108389. PMID: 33865691; PMCID: PMC8384640; DOI: 10.1016/j.jsat.2021.108389;
     
  10. Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Kudo M, Breder V, Merle P, Kaseb AO, Li D, Verret W, Xu DZ, Hernandez S, Liu J, Huang C, Mulla S, Wang Y, Lim HY, Zhu AX, Cheng AL. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020 May 14; 382(20):1894-1905. PMID: 32402160
     
Showing 10 of 19 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 19 publications over 12 distinct years, with a maximum of 3 publications in 2024

YearPublications
20101
20111
20131
20142
20151
20182
20191
20201
20212
20222
20243
20252

Contact for Mentoring:

Cheng's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (109) concept(s)
_
Co-Authors
See all (4) people
_
Similar People
See all (60) people
_